An underground market for unlicensed weight-loss medications is being driven by social media fitness personalities and sellers on messaging platforms, according to new investigations.
Investigational Treatment Gaining Traction Via Social Media
Retatrutide, which remains in research studies, is being advertised by online personalities for its supposed weight-reducing effects. Viewers are encouraged to contact these profiles directly for supplier links, while also obtaining promotional offers.
Thriving Commerce on Messaging Platforms
Separately, a flourishing trade exists on Telegram, where communities with thousands of members share comparison images, administration instructions and assertions of rapid UK delivery. Vendors market the substance there before directing buyers to other platforms for purchases.
Learning About The Experimental Drug
This medication is an investigational injection developed by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies indicate it could assist patients reduce up to 25% of their total weight. Referred to as the “triple G”, the drug is being hailed digitally as the next Ozempic.
Healthcare Professionals Voice Worries
Nevertheless, doctors and pharmacists have cautions that the distribution of what is still an unapproved drug in the United Kingdom is worrisome and could result in individuals administering products of uncertain source.
Several experts stated the demand for retatrutide could be linked to the rising price of approved slimming products such as Mounjaro.
Regulatory Position and Implementation
Marketing retatrutide on social media or Telegram is prohibited in the United Kingdom, as it is an unapproved medication that must not be promoted or distributed for personal consumption under the British medical regulations.
Some influencers try to circumvent the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but promotion and supply can still violate pharmaceutical, marketing, and consumer laws, risking fines, prosecution or imprisonment.
Service Reaction and Material Removal
Based on TikTok, the platform has taken down problematic content and prohibited related hashtags and search suggestions. The organization stated it was committed to maintaining the service secure and allocating resources in strengthening compliance measures.
Online Trading Activities
Investigations also found groups with up to 9,000 participants selling retatrutide using the platform's built-in search feature, which functions like a public directory. Typing “retatrutide” immediately displays channels with numerous of users, filled with photos of weight loss, glowing reviews and step-by-step instructions for mixing or administering at home.
Within moments of entering one community, a seller posted contact information, where the majority of purchases occur. The vendor provided an guidebook and promised delivery within 48 hours. When questioned whether the product was genuine, one seller said: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. Not one asked about body mass, health issues or previous experience.
Item Details and Costs
Within these groups, posts show black plastic parcels with Royal Mail stickers, stating to include fresh supplies. One message stated: “It took eight of us to load them this morning.”
Customers can choose between powder vials, mixed at residence with sterile water, or ready-to-use injectors typically priced at £160 for 20mg. When questioned how much time a injector should be used, vendors give conflicting answers ranging from a few weeks to “depends on your body”.
Service Moderation and Security Actions
A spokesperson for the messaging service said it regularly monitored dangerous content on its service including material that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“Individuals are injecting materials they can’t verify. Although the science behind retatrutide is valid, these online versions may not contain what they advertise,” stated a pharmacy expert, the director of pharmacy at a pharmacy service.
A medical professional of an online medical service linked the increase in demand to recent price rises for approved weight-loss drugs such as Mounjaro. “With prices rising, patients are using online platforms. But counterfeit treatments are extremely risky. You cannot know what’s inside or whether the conditions they were made in was sterile,” she explained.
Her team has already encountered individuals injured by self-injection from unconfirmed sources. “We recognize the frustration, but purchasing from messaging apps or WhatsApp is gambling with your well-being,” said the doctor. “These substances could be impure or improperly measured.”
Producer Statement
A spokesperson from the pharmaceutical company stated the substance was in third stage research studies and had not been reviewed or approved by any regulatory agency anywhere in the world. “Therefore at this point no one can sell [it] for human use,” they explained, adding that any item “falsely representing itself as a company experimental product not yet authorized … may expose users to potentially significant medical dangers”.
